3B21ICD-11 MMS 2026-01
Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors
Description
A disease caused by anticoagulants present in the body that prevent the blood from clotting normally. This disease is characterised by abnormalities in blood clotting. This disease may present with prolonged bleeding, easy bruising or bleeding gums. Confirmation is by identification of anticoagulants present in a blood sample.
Excludes
QC48.0– long-term use of anticoagulants without haemorrhage
Exclusions from above levels
KA8F.0– vitamin K deficiency of newbornJA43.3– Postpartum coagulation defects04– Diseases of the immune system
Show allHide
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth or the puerperium19– Certain conditions originating in the perinatal period20– Congenital malformations, deformations or chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes- http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1– Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium
Child codes
3B21.0– Haemorrhage due to thrombin inhibitor other than heparin3B21.1– Haemorrhage due to factor Xa inhibitor3B21.Y– Haemorrhagic disorder due to other specified circulating anticoagulants or coagulation factors3B21.Z– Haemorrhagic disorder due to unspecified circulating anticoagulants or coagulation factors
Sibling codes
Foundation entity
Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors – http://id.who.int/icd/entity/156218529
Allowed postcoordination axes
Part of: 03: Diseases of the blood or blood-forming organs